Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PODOPHYLLOTOXIN
Stiefel Laboratories (U.K.) Ltd.
0.5%w/v %w/v
Cutaneous Solution
1993-11-17
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Warticon Solution 0.5% w/v Cutaneous Solution. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Podophyllotoxin 0.5% w/v For excipients, see 6.1. 3 PHARMACEUTICAL FORM Cutaneous solution. A blue coloured solution for cutaneous use. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of anogenital warts (Condylomata Acuminata) 4.2 POSOLOGY AND METHOD OF ADMINSTRATION The following doses and schedules are applicable to adults and the elderly. The affected area should be thoroughly washed with soap and water and dried prior to application. Using the applicator provided, the warts should be painted twice daily for three days. The treated area should be allowed to dry. Residual warts should be treated with further courses of twice daily applications for 3 days after a 4 day treatment-free period. Normally 3 - 4 treatment courses are sufficient. The majority of patients will not require in excess of 30 loops for each application, however, a maximum of 50 loops per application (equivalent to 250µl of Warticon solution) may be applied. Where lesions are greater in area than 4cm 2 , it is recommended that treatment takes place under the direct supervision of medical staff. 4.3 CONTRAINDICATIONS Open wounds following surgical procedures should not be treated with podophyllotoxin. Hypersensitivity to podophyllotoxin is a contraindication. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE Be careful to apply Warticon solution to the warts only; if any spreads onto healthy skin it should be washed off with soap and water. Avoid contact with the eyes. Following accidental spillage the skin should be washed well with soap and water. In the IRISH MEDICINES BOARD _______________________________________________________________________________________________________________________ Read the complete document